This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Prostate Cancer
and you are
-
The phase for this study is not defined.
Show me locations

The purpose

The investigators will evaluate the accuracy of performing cytological imprints of targeted biopsies when diagnosing prostate cancer. It is useful to know whether the biopsy is cancer or not, in order to know when to stop sampling and when to continue. The strategy is used in other types of cancer, e.g lung, breast etc

Provided treatments

  • Other: Cytological imprints

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01745718. The sponsor of the trial is Oslo University Hospital and it is looking for 0 volunteers for the current phase.
Official trial title:
Targeted Biopsies and the Role of Cytological Imprints for Diagnosis of Prostate Cancer